trending Market Intelligence /marketintelligence/en/news-insights/trending/rdkxuwrvc2c1oxv2iyj-1a2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Cesca Therapeutics to raise $1.4M in registered direct offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Cesca Therapeutics to raise $1.4M in registered direct offering

Cesca Therapeutics Inc. is selling 609,636 common shares at $2.27 apiece and unregistered warrants to buy up to 304,818 common shares in a registered direct offering with certain institutional investors.

Each warrant is exercisable for $2.68 apiece six months after the issuance date and will expire within a 5.5-year period.

Gross proceeds from the offering are expected to amount to about $1.4 million. The offering is expected to close March 28, subject to customary closing conditions.

H.C. Wainwright & Co. is acting as the exclusive placement agent in the offering.